Literature DB >> 25495752

Use of novel oral anticoagulants in patients with end-stage renal disease.

Wolfgang C Winkelmayer1, Charles A Herzog, Maria E Montez-Rath, Tara I Chang, Glenn M Chertow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25495752     DOI： 10.1111/hdi.12251

Source DB:  PubMed          Journal:  Hemodial Int        ISSN： 1492-7535            Impact factor:   1.812


× No keyword cloud information.
  2 in total

Review 1.  Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation.

Authors:  Austin Hu; Jingbo Niu; Wolfgang C Winkelmayer
Journal:  Semin Nephrol       Date:  2018-11       Impact factor: 5.299

2.  Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Mintu P Turakhia; Peter J Blankestijn; Juan-Jesus Carrero; Catherine M Clase; Rajat Deo; Charles A Herzog; Scott E Kasner; Rod S Passman; Roberto Pecoits-Filho; Holger Reinecke; Gautam R Shroff; Wojciech Zareba; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christoph Wanner
Journal:  Eur Heart J       Date:  2018-06-21       Impact factor: 29.983
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.